Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
T cell responses after hematopoietic stem cell transplantation for aggressive relapsing-remitting multiple sclerosis.
Seroprevalence of NMO-IgG Antibody in Neuromyelitis optica (NMO) and Its Specificity in Differentiating NMO from Other Demyelinating Diseases with Overlap Symptoms: An Iranian Experience.
Elevated Cerebrospinal Fluid Opening Pressure in a Pediatric Demyelinating Disease Cohort.
Difficulties with emotion regulation in multiple sclerosis: Links to executive function, mood, and quality of life.
Gait kinematics of people with Multiple Sclerosis and the acute application of Functional Electrical Stimulation.
Genomic Binding Sites and Biological Effects of the Vitamin D: VDR Complex in Multiple Sclerosis.
Substance Name: Simvastatin
Quantification of diagnostic biomarkers to detect multiple sclerosis lesions employing (1)H-MRSI at 3T.
Safety and efficacy of natalizumab in children with multiple sclerosis.
FDA warns about the risks of unproven surgical therapy for multiple sclerosis.
Lack of replication of interaction between EBNA1 IgG and smoking in risk for multiple sclerosis.
The Interdependent, Overlapping, and Differential Roles of Type I and II IFNs in the Pathogenesis of Experimental Autoimmune Encephalomyelitis.
Subcutaneous IgG in neurologic diseases.
Quantifying Missing Heritability at Known GWAS Loci.
Il-17 And Glutamte Excitotoxicity In The Pathogenesis Of Multiple Sclerosis.
Comparison of Sleep Problems in Individuals with Spinal Cord Injury and Multiple Sclerosis.
Advanced techniques using contrast media in neuroimaging.
Natalizumab: Bench to Bedside and Beyond.
Cerebrospinal fluid oligoclonal IgM bands predict early conversion to clinically definite multiple sclerosis in patients with Clinically Isolated Syndrome.
Advanced magnetic resonance imaging in pediatric multiple sclerosis.
Use of imaging to study leukocyte trafficking in the central nervous system.
Natalizumab therapy for multiple sclerosis.
Interaction between passive smoking and two HLA genes with regard to multiple sclerosis risk.
Saffold cardiovirus and multiple sclerosis: no evidence for an association.
Melatonin Redox Activity. Its Potential Clinical Application in Neurodegenerative Disorders.
Pages
« first
‹ previous
…
415
416
417
418
419
420
421
422
423
…
next ›
last »